Mar Llamas-Velasco Selected Research

Mar Llamas-Velasco Research Topics

Disease

40	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 12/2013
11	Neoplasms (Cancer) 01/2024 - 04/2015
5	Psoriatic Arthritis 12/2023 - 09/2018
4	Necrosis 10/2023 - 06/2015
2	Inflammation (Inflammations) 03/2024 - 01/2023
2	Atherosclerosis 03/2024 - 11/2023
2	Infections 01/2024 - 10/2023
2	Mycoses (Diseases, Fungus) 01/2023 - 06/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2020 - 05/2014
2	Cysts 01/2019 - 04/2018
2	Erythema 03/2018 - 03/2013
2	Histiocytosis 09/2017 - 06/2015
2	Panniculitis 06/2015 - 01/2013
2	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 05/2015 - 01/2013
1	Insulin Resistance 03/2024
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2024
1	Tuberculosis (Tuberculoses) 01/2024
1	Latent Tuberculosis 01/2024
1	Atherosclerotic Plaque (Atheroma) 11/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Hidradenitis Suppurativa 01/2023
1	Multiple Sclerosis 01/2023
1	Spondylarthritis (Spinal Arthritis) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Axial Spondyloarthritis 01/2023
1	Skin Manifestations 11/2022
1	Rheumatoid Arthritis 08/2022
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Liver Diseases (Liver Disease) 06/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Obesity 12/2021
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Melanoma (Melanoma, Malignant) 10/2021
1	COVID-19 02/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Hypopigmentation (Hypomelanosis) 11/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020

Drug/Important Bio-Agent (IBA)

8	secukinumabIBA 01/2024 - 09/2018
5	Interleukin-23 (Interleukin 23)IBA 01/2024 - 11/2022
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2016
4	Adalimumab (Humira)FDA Link 11/2022 - 12/2013
3	InterleukinsIBA 02/2024 - 11/2022
3	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2023
3	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 07/2020
3	guselkumabIBA 11/2022 - 01/2022
3	Ustekinumab (CNTO 1275)FDA Link 10/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
3	Etanercept (Enbrel)FDA Link 07/2020 - 06/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 02/2022
2	C-Reactive ProteinIBA 03/2024 - 11/2020
2	MucinsIBA 01/2024 - 01/2021
2	tildrakizumabIBA 12/2023 - 10/2023
2	Dimethyl FumarateIBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2019
2	AntibodiesIBA 06/2022 - 01/2019
2	InterferonsIBA 11/2020 - 01/2016
2	Infliximab (Remicade)FDA Link 07/2020 - 01/2018
2	Acitretin FDA Link 07/2020 - 12/2013
2	CollagenIBA 03/2019 - 01/2019
2	Keratins (Keratin)IBA 06/2018 - 04/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2018 - 01/2013
1	Certolizumab Pegol FDA Link 05/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024
1	HDL LipoproteinsIBA 03/2024
1	CCR4 ReceptorsIBA 02/2024
1	mogamulizumabIBA 02/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	ixekizumabIBA 01/2024
1	Oxygen (Dioxygen)IBA 11/2023
1	Complement System Proteins (Complement)IBA 11/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Biosimilar PharmaceuticalsIBA 11/2022
1	DesminIBA 06/2022
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 02/2022
1	CytokinesIBA 02/2022
1	EnzymesIBA 02/2022
1	Tissue Inhibitor of Metalloproteinase-3IBA 02/2022
1	RivaroxabanIBA 01/2022
1	FibrinIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 10/2021
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 10/2021
1	Ferritins (Ferritin)IBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	fibrin fragment D (D-dimer)IBA 11/2020
1	apremilastIBA 07/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2020

Therapy/Procedure

10	Therapeutics 10/2023 - 01/2018
8	Biological Therapy 01/2024 - 12/2018
3	Drug Therapy (Chemotherapy) 02/2015 - 01/2013
2	Aftercare (After-Treatment) 10/2022 - 01/2020
1	Chemoprevention 01/2024
1	Drug Tapering 01/2024
1	Pain Management 01/2022